TGTX - TG Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TGTX is currently covered by 3 analysts with an average price target of $43.76. This is a potential upside of $12.78 (41.25%) from yesterday's end of day stock price of $30.98.

TG Therapeutics's activity chart (see below) currently has 142 price targets and 104 ratings on display. The stock rating distribution of TGTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 77.59% with an average time for these price targets to be met of 499.53 days.

Highest price target for TGTX is $55, Lowest price target is $49, average price target is $53.

Most recent stock forecast was given by ERIC JOSEPH from JPMORGAN on 03-Nov-2025. First documented stock forecast 22-Jul-2014.

Currently out of the existing stock ratings of TGTX, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$49

$15.74 (47.32%)

$43

1 months 16 days ago
(03-Nov-2025)

8/9 (88.89%)

$15.31 (45.44%)

192

Buy

$55

$21.74 (65.36%)

$53

3 months 2 days ago
(17-Sep-2025)

14/16 (87.5%)

$22.96 (71.66%)

304

Buy

$55

$21.74 (65.36%)

$55

9 months 15 days ago
(04-Mar-2025)

14/21 (66.67%)

$19.38 (54.41%)

329

Hold

$22

$-11.26 (-33.85%)

$20

1 years 1 months 14 days ago
(05-Nov-2024)

5/8 (62.5%)

$-3.86 (-14.93%)

147

Buy

$24

$-9.26 (-27.84%)

$24

2 years 8 months 2 days ago
(17-Apr-2023)

3/3 (100%)

$3.45 (16.79%)

299

Show more analysts

Please expand the browser size to see the chart

What is TGTX (TG Therapeutics) average time for price targets to be met?

On average it took 499.53 days on average for the stock forecasts to be realized with a an average price target met ratio 77.59

Which analyst has the current highest performing score on TGTX (TG Therapeutics) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on TGTX (TG Therapeutics)?

Yatin Suneja works at GUGGENHEIM and has 9 price targets and 5 ratings on TGTX

Which analyst is the currently most bullish on TGTX (TG Therapeutics)?

Matthew Kaplan with highest potential upside - $54.89

Which analyst is the currently most reserved on TGTX (TG Therapeutics)?

Alec Stranahan with lowest potential downside - -$27.26

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?